Relation between thyroid hormonal status, neutrophillymphocyte ratio and left ventricular systolic function in

Mirela Halilčević1, Edin Begić2,3, Amela Džubur4

  • 1Department of Cardiology, Clinic for Heart, Blood Vessel and Rheumatic Diseases, Clinical Centre University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

Insights

Thyroid function and neutrophil-lymphocyte ratio (NLR) impact left ventricular ejection fraction (LVEF) in acute myocardial infarction patients. Hypothyroidism is linked to worse outcomes and more severe coronary artery disease.

Area of Science:

  • Cardiology
  • Endocrinology
  • Inflammation Research

Background:

  • Acute myocardial infarction (AMI) patients exhibit altered thyroid function and elevated inflammatory markers.
  • Left ventricular ejection fraction (LVEF) is a key indicator of cardiac function post-AMI.
  • The neutrophil-lymphocyte ratio (NLR) serves as a marker of systemic inflammation.

Purpose of the Study:

  • To investigate the relationship between thyroid function, NLR, and LVEF in AMI patients undergoing percutaneous coronary intervention (PCI).
  • To assess the association between thyroid status and the severity of coronary artery disease.

Main Methods:

  • Prospective study of 160 AMI patients, divided into euthyroid (n=80) and newly diagnosed hypothyroid (n=80) groups.
  • Analysis of thyroid hormones (TSH, T3, T4, FT3, FT4) and inflammatory markers (NLR, CRP).
  • Transthoracic echocardiography (TTE) to measure LVEF five days post-admission.

Main Results:

  • Significant differences in T3, T4, hematological parameters, NLR, CRP, and sedimentation rate between euthyroid and hypothyroid groups.
  • Euthyroid patients showed a higher frequency of single-vessel disease and lower frequency of triple-vessel disease.
  • LVEF significantly correlated with hemoglobin, NLR, and CRP; euthyroid patients had higher LVEF.

Conclusions:

  • Altered thyroid status in AMI is associated with coronary lesion severity and impaired LVEF.
  • Thyroid dysfunction correlates with the inflammatory response in AMI patients.
  • NLR and CRP are significant correlates of LVEF in this patient cohort.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
24
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
33
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
138
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20